Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; LX9211, which is in Phase II clinical development for the treatment […]
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. Available vaccines are now available for distribution […]
Read MoreBuy Price: $7.80 or better Sell Price: TradersPro Sell Signal Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also develops XIPERE, a […]
Read MoreThe AES Corporation (AES) The AES Corporation operates as a diversified power generation and utility company. It owns and/or operates power plants to generate and sell power to customers, such as utilities, industrial users, and other intermediaries. The company also owns and/or operates utilities to generate or purchase, distribute, transmit, and sell electricity to end-user […]
Read MorePlus, Dick’s Sporting Goods reported sales growth of 21% for the second quarter, American Airlines warned that rising COVID infections are denting August revenue, and Microsoft said its cloud gaming services is coming to new Xbox devices this holiday season.
Read MorePlus, Best Buy delivered an earnings beat, top tech executives are expected to meet with President Biden at the White House tomorrow to discuss cybersecurity, and Peloton announced its new Tread treadmill.
Read MorePlus, Lyft and Uber shares opened lower after a California court ruled that a ballot measure that exempted gig workers from state labor law was unconstitutional, PayPal said it is opening its crypto service to users in the U.K., and Sir Richard Branson’s Virgin Orbital is going public via a SPAC merger.
Read MorePlus, AstraZeneca said its antibody therapy reduced the risk of developing COVID-19 symptoms by 77%, The Topps Co’s SPAC merger is off, and Elon Musk announced the Tesla Bot.
Read MorePlus, the FDA authorized COVID-19 booster shots for people with weakened immune systems, Disney delivered an earnings beat, and space company Momentus debuted on the Nasdaq.
Read MorePlus, Apple is reportedly planning to make major camera and video upgrades to its new lineup of iPhones, AMC reported a narrower-than-expected loss, and Robinhood is buying Say Technologies.
Read MorePlus, Pfizer could see full FDA approval for its COVID-19 vaccine in the coming weeks, Roku is adding another 23 shows from Quibi to its collection of original content, and Berkshire Hathaway reported an operating earnings jump of 21% year-over-year.
Read MorePlus, Virgin Galactic shares are up after the company announced it is reopening ticket sales for its space flights, Novavax said it is delaying submission to the FDA for emergency use authorization for its COVID-19 vaccine until the fourth quarter, and Levi Strauss is breaking into the athletic apparel industry in purchasing Beyond Yoga.
Read MoreThere is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]
Read MoreBuy Price: $46.50 or better Sell Price: TradersPro Sell Signal Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The stocks founds in the One Hot Stock category use […]
Read MorePlus, Gap’s Athleta brand is launching a workout and wellness platform, Tesla is reportedly moving its showrooms out of malls, and ride sharing app Swvl is going public via a reverse merger with a SPAC.
Read More